• Je něco špatně v tomto záznamu ?

Immune Response 5-7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines

J. Martínek, H. Tomášková, J. Janošek, H. Zelená, A. Kloudová, J. Mrázek, E. Ježo, V. Král, J. Pohořská, H. Šturcová, R. Maďar

. 2022 ; 14 (5) : . [pub] 20220518

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018381

BACKGROUND AND AIMS: Elderly nursing home residents are especially prone to a severe course of SARS-CoV-2 infection. In this study, we aimed to investigate the complex immune response after vaccination depending on the convalescence status and vaccine. METHODS: Sampling took place in September-October 2021. IgG antibodies against spike protein and nucleocapsid protein, the titer of virus neutralization antibodies against delta and (on a subset of patients) omicron, and cellular immunity (interferon-gamma release assay) were tested in nursing home residents vaccinated with Pfizer, Moderna (both 30-31 weeks after the completion of vaccination), or AstraZeneca (23 weeks) vaccines. The prevalence with 95% confidence intervals (CI) was evaluated in Stata version 17. RESULTS: 95.2% (95% CI: 92.5-97.1%) of the 375 participants had positive results of anti-S IgG, 92.8% (95% CI: 89.7-95.2%) were positive in virus neutralization assay against delta, and 89.0% (95% CI: 84.5-92.5%) in the interferon-gamma-releasing assay detecting cellular immunity. Results of the virus neutralization assay against omicron correlated with those against delta but the neutralization capacity was reduced by about half. As expected, the worst results were found for the AstraZeneca vaccine, although the vaccination-to-test period was the shortest for this vaccine. All immune parameters were significantly higher in convalescent residents than in naive residents after vaccination. No case of COVID-19 occurred during the vaccination-to-test period. CONCLUSIONS: A high immune response, especially among vaccinated convalescents (i.e., residents with hybrid immunity), was found in elderly nursing home residents 5-7 months after vaccination against SARS-CoV-2. In view of this, it appears that such residents are much better protected from COVID-19 than those who are only vaccinated and the matter of individual approach to the booster dose in such individuals should be further discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018381
003      
CZ-PrNML
005      
20220804134734.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/v14051086 $2 doi
035    __
$a (PubMed)35632827
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Martínek, Jan $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000168697391
245    10
$a Immune Response 5-7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines / $c J. Martínek, H. Tomášková, J. Janošek, H. Zelená, A. Kloudová, J. Mrázek, E. Ježo, V. Král, J. Pohořská, H. Šturcová, R. Maďar
520    9_
$a BACKGROUND AND AIMS: Elderly nursing home residents are especially prone to a severe course of SARS-CoV-2 infection. In this study, we aimed to investigate the complex immune response after vaccination depending on the convalescence status and vaccine. METHODS: Sampling took place in September-October 2021. IgG antibodies against spike protein and nucleocapsid protein, the titer of virus neutralization antibodies against delta and (on a subset of patients) omicron, and cellular immunity (interferon-gamma release assay) were tested in nursing home residents vaccinated with Pfizer, Moderna (both 30-31 weeks after the completion of vaccination), or AstraZeneca (23 weeks) vaccines. The prevalence with 95% confidence intervals (CI) was evaluated in Stata version 17. RESULTS: 95.2% (95% CI: 92.5-97.1%) of the 375 participants had positive results of anti-S IgG, 92.8% (95% CI: 89.7-95.2%) were positive in virus neutralization assay against delta, and 89.0% (95% CI: 84.5-92.5%) in the interferon-gamma-releasing assay detecting cellular immunity. Results of the virus neutralization assay against omicron correlated with those against delta but the neutralization capacity was reduced by about half. As expected, the worst results were found for the AstraZeneca vaccine, although the vaccination-to-test period was the shortest for this vaccine. All immune parameters were significantly higher in convalescent residents than in naive residents after vaccination. No case of COVID-19 occurred during the vaccination-to-test period. CONCLUSIONS: A high immune response, especially among vaccinated convalescents (i.e., residents with hybrid immunity), was found in elderly nursing home residents 5-7 months after vaccination against SARS-CoV-2. In view of this, it appears that such residents are much better protected from COVID-19 than those who are only vaccinated and the matter of individual approach to the booster dose in such individuals should be further discussed.
650    _2
$a senioři $7 D000368
650    12
$a COVID-19 $x epidemiologie $x prevence a kontrola $7 D000086382
650    _2
$a lidé $7 D006801
650    _2
$a imunita $7 D007109
650    _2
$a imunoglobulin G $7 D007074
650    _2
$a pečovatelské domovy $7 D009735
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a vakcinace $7 D014611
650    12
$a vakcíny $7 D014612
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tomášková, Hana $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000296081276 $7 pna2008424773
700    1_
$a Janošek, Jaroslav $u Centre for Health Research, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000306824521
700    1_
$a Zelená, Hana $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
700    1_
$a Kloudová, Alena $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
700    1_
$a Mrázek, Jakub $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
700    1_
$a Ježo, Eduard $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
700    1_
$a Král, Vlastimil $u Institute of Public Health Ústí nad Labem, Moskevská 1531/15, 400 01 Ústí nad Labem, Czech Republic
700    1_
$a Pohořská, Jitka $u Institute of Public Health Ústí nad Labem, Moskevská 1531/15, 400 01 Ústí nad Labem, Czech Republic
700    1_
$a Šturcová, Hana $u Institute of Public Health Ústí nad Labem, Moskevská 1531/15, 400 01 Ústí nad Labem, Czech Republic
700    1_
$a Maďar, Rastislav $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic
773    0_
$w MED00177099 $t Viruses $x 1999-4915 $g Roč. 14, č. 5 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35632827 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134728 $b ABA008
999    __
$a ok $b bmc $g 1822127 $s 1169624
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 5 $e 20220518 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...